Akerman LLP, a leading law firm serving clients across the Americas, today announced that William J. Spratt, Jr. has joined as a partner in the firm’s Healthcare Practice Group in Miami. Spratt joins Akerman from K&L Gates, bringing 25 years of experience representing the healthcare industry.
Spratt has represented virtually all sectors of the healthcare industry in governance, compliance and transactional matters. He has represented large companies and private equity sponsors in multi-jurisdictional transactions, including acquisitions, sales, mergers, and reorganizations of healthcare businesses, traversing complex state and federal healthcare laws and regulations. A former healthcare administrator, he has a diverse healthcare practice representing local, regional, national and international clients.
“There are few lawyers in the United States with Bill’s healthcare regulatory and transactional background,” said Kirk Davis, chair of Akerman’s Healthcare Practice Group. “Bill’s experience in health administration, coupled with his transactional acumen, will be of great value to our private equity and institutional healthcare clients and further expand our national reach in this rapidly growing area.”
“It is great to be practicing at Akerman with so many old and new friends,” Spratt said. “With so many terrific health lawyers and an impressive group of M&A lawyers in one of the country’s leading law firms, Akerman is a great fit for my practice and my clients.”
Spratt is recognized by Chambers USA and The Best Lawyers in America as a leading healthcare lawyer. He also has taught health law as an adjunct faculty member in the Master of Health Administration programs at Florida Atlantic University and Nova Southeastern University. Board Certified in Health Law by The Florida Bar, he is the fourth lawyer in Akerman’s Healthcare Practice Group to previously serve as chair of The Florida Bar Health Law Certification Committee.
Spratt will work closely with the firm’s M&A and Private Equity lawyers. Earlier this year, Akerman completed significant deals within the health and pharmaceutical industries, including a $480 million stock acquisition of PROLOR Biotech, Inc. on behalf of OPKO Health Inc., as well as its $290 million acquisition of Cytochroma Inc.
Akerman’s Healthcare M&A Practice includes a multi-disciplinary team of lawyers experienced in advising public and private healthcare companies, including private equity funds, in mergers & acquisitions and other transactional and regulatory matters, with a strong focus on the middle market. Our team is recognized nationally by U.S. News – Best Lawyers for Healthcare Law as well as for Corporate, M&A, Private Equity, Securities/Capital Markets, and Securities Regulation Law. Akerman’s Healthcare Practice Group provides counsel on complex regulatory, risk management, and corporate matters to a broad range of industry stakeholders.
For the second consecutive year, the firm’s Healthcare Practice Group was recognized as one of the top 50 in the United States by Modern Healthcare in its annual list of ‘Largest Healthcare Law Firms in the United States.’ Akerman lawyers share timely updates on trending issues in the healthcare industry on Akerman’s Health Law Rx Blog, available here.
